about
Inhibition of hedgehog signaling decreases proliferation and clonogenicity of human mesenchymal stem cells.Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinomaThe mitochondrial transport protein SLC25A43 affects drug efficacy and drug-induced cell cycle arrest in breast cancer cell linesIdentification of four novel susceptibility loci for oestrogen receptor negative breast cancerMitochondrial regulation of cell cycle progression through SLC25A43.Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.Cohort profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA).Altered PPARγ Coactivator-1 Alpha Expression in Abdominal Aortic Aneurysm: Possible Effects on Mitochondrial Biogenesis.Association analysis identifies 65 new breast cancer risk loci.Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancerGenomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibilityPolygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesAssociations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysisInterval breast cancer is associated with other types of tumorsThe FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerMammographic Density Change and Risk of Breast CancerDeterminants of Mammographic Density Change
P50
Q33815303-4F0D8090-8464-4868-843D-798983FE35D9Q34223682-87ED14E8-3B57-497B-8B27-93F53893440CQ36753310-724263BD-B900-401B-92A0-41E4965B1DDCQ36859142-703459A8-8C6F-462A-9940-57736266E8EBQ38807435-DC6FA4D5-6EB4-4E04-BD96-34F5FF13446AQ38823212-38CB0E7E-EA8F-4A7D-B5DA-649FC72DF157Q40343406-DCA676DA-E6CB-4EDE-8BD3-DFE299206CF2Q40537327-4829D4E4-7DC3-4403-B85D-B9E568147F93Q45979098-507F0660-4A1F-42F3-A337-C008A2ED7CA9Q46103372-A444D233-C97D-407C-8FD4-51E8E7468A29Q47143943-809FF1D7-8EE3-4A38-BA87-D8261BC2557BQ47190168-6B9C6031-1780-42E5-BBDF-3103F792F534Q49817640-DF1DC1F3-9511-4025-987D-2FCEDE510467Q57305942-981D1CB0-0ABF-4C2C-9172-11613E6C22E2Q59566871-71361621-5C81-4A7C-8765-C2494AB393C6Q62583133-6DC474CC-5C3B-49AF-8381-C0BEB9C23736Q62583318-76E82CBB-0EA0-400F-8D28-B38D2D55523AQ90883907-4F19D920-033D-4312-8C9E-697D12B6372BQ91178389-41F6FC1C-7DB8-4A6A-9BB5-3DEFD9413FCAQ91824346-26E7B424-88C7-43A4-93D4-59DDC81AE2F1Q92282083-37F4F12E-81B1-470F-B426-1CF1239F6452
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marike Gabrielson
@ast
Marike Gabrielson
@en
Marike Gabrielson
@es
Marike Gabrielson
@nl
type
label
Marike Gabrielson
@ast
Marike Gabrielson
@en
Marike Gabrielson
@es
Marike Gabrielson
@nl
altLabel
Gabrielson M
@en
prefLabel
Marike Gabrielson
@ast
Marike Gabrielson
@en
Marike Gabrielson
@es
Marike Gabrielson
@nl
P106
P31
P496
0000-0002-3171-1556